![Tikoes Blankenberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Origen de la red de primer grado Tikoes Blankenberg.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Flow Pharma, Inc.
![]() Flow Pharma, Inc. Internet Software/ServicesTechnology Services Flow Pharma, Inc.operates as t-cell based vaccine delivery platform. The company was founded by Reid Rubsamen and is headquartered in Pleasant Hill, CA.
4
| Holding Company | Internet Software/Services | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Tikoes Blankenberg a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
SteadyMed Therapeutics, Inc.
![]() SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Steadymed Therapeutics, Inc. develops drug delivery therapeutics devices. The company was founded by Amir Genosar, Ian Solomon and Gideon Kahana in 2005 and is headquartered in San Ramon, CA. | Medical/Nursing Services | Director/Board Member | |
Cerebral Therapeutics, Inc.
![]() Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cerebral Therapeutics, Inc. develops neurological therapeutics for uncontrolled neurological diseases. It is a clinical-stage company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The firm offers long-term implanted drug-device combination therapies that bypass the blood-brain barrier to deliver optimal doses of specially formulated neurological therapeutics directly into the target region of the brain. The company was founded by Daniel J. Abrams and James P. Kelleher and is headquartered in Aurora, CO. | Miscellaneous Commercial Services | Chairman | |
De Montfort University | College/University | Undergraduate Degree | |
Welsh School of Pharmacy | College/University | Corporate Officer/Principal | |
Zogenix Europe Ltd.
![]() Zogenix Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of UCB SA, Zogenix Europe Ltd. develops and commercializes pharmaceutical products. The company is based in Lewins Mead, UK. Zogenix Europe was founded in 2010. | Pharmaceuticals: Major | Director/Board Member | |
Oscillari LLC | Director/Board Member | ||
Zogenix International Ltd.
![]() Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Zogenix International Ltd. manufactures and markets pharmaceutical products. It develops Brabafen an oral treatment for use in children with Dravet Syndrome or severe myoclonic epilepsy of infancy. The company was founded in 2012 and is headquartered in Maidenhead, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Royal Pharmaceutical Society of Great Britain
![]() Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ICVRx LLC | Director/Board Member | ||
The University of Wales | College/University | Doctorate Degree | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Ibadan | College/University | Doctorate Degree | |
ZOGENIX, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Revolo Biotherapeutics Ltd.
![]() Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Veloxis Pharmaceuticals, Inc.
![]() Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Asahi Kasei Corp., Veloxis Pharmaceuticals, Inc. manufactures pharmaceuticals for kidney transplant patients. The company is based in Edison, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
MALLINCKRODT PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Boehringer Ingelheim Pharmaceuticals, Inc.
![]() Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Mallinckrodt Pharmaceuticals Ltd.
![]() Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ALLERGY THERAPEUTICS PLC | Pharmaceuticals: Other | Director/Board Member | |
Center for Drug Evaluation & Research | General Government | Chief Tech/Sci/R&D Officer | |
University of California, Davis | College/University | Corporate Officer/Principal | |
United Nations Environment Programme | General Government | Corporate Officer/Principal | |
Tevard Biosciences, Inc.
![]() Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Tevard Biosciences, Inc. is a biotechnology company based in Cambridge, MA. Tevard Biosciences is focused on developing trna-based and other modulating therapies to cure a broad range of genetic diseases. The company is advancing the use of its novel suppressor trna, enhancer trna, and mrna amplifier platforms in neurological disorders, heart disease, and muscular dystrophies. The company was founded in 2017 by Warren Burt Lammert, Harvey F. Lodish, Daniel Fischer, and Jeffrey Coller. Daniel Fischer has been the CEO since 2017. | Miscellaneous Commercial Services | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 13 |
Reino Unido | 10 |
Israel | 2 |
Dinamarca | 2 |
Nigeria | 2 |
Sectorial
Health Technology | 13 |
Consumer Services | 6 |
Commercial Services | 4 |
Government | 3 |
Health Services | 2 |
Operativa
Director/Board Member | 15 |
Chief Tech/Sci/R&D Officer | 10 |
Corporate Officer/Principal | 4 |
Doctorate Degree | 2 |
Chief Executive Officer | 2 |
Las relaciones más conectadas
Insiders | |
---|---|
Stephen Farr | 16 |
Babatunde Otulana | 13 |
Reid Rubsamen | 1 |
Pamela Steele | 1 |
- Bolsa de valores
- Insiders
- Tikoes Blankenberg
- Conexiones Empresas